4
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-058413
Chief Finance & Strat Officer sold 1,388 shares at $13.51 ($18,752)
- Chief Finance & Strat Officer acquired 5,237 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Option exercise | +5,237 | 128,218 | D | ||
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Sale | −1,388 | $13.51 | $18,752 | 126,830 | D |
| Derivatives | |||||||
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Option exercise · Restricted Stock Units | −5,237 | 5,237 | D | ||
| Open-market sales · 1,388 sh · avg $13.51 · $18,752 | |||||||
Loading xslF345X05/wk-form4_1766416244.xml…